Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer | Future Oncology
HAT inhibitors in cancer therapy - ScienceDirect
Histone acetyltransferase (HAT) activation as a therapeutic strategy.... | Download Scientific Diagram
A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy | Bentham Science
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram
CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor - Network of Cancer Research
Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology
Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
Cancers | Free Full-Text | Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer | HTML
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry
KATs in cancer: functions and therapies | Oncogene
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
Histone deacetylase modulators provided by Mother Nature | Genes & Nutrition | Full Text
HAT inhibitors in cancer therapy - ScienceDirect
Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast and human cell lines - Huang - 2020 - Aging Cell - Wiley Online Library
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text
